Authors



Todd Stein

Latest:

Leaders in academic ophthalmology discuss AI for eye screening

Artificial intelligence in a primary care and clinic settings increases the likelihood of catching diabetic retinopathy in underinsured patients, resulting in increased successful referrals.



Winfried Amoaku, FRCS, FRCOphth, PhD, AFHEA

Latest:

Pearls for managing diabetic retinopathy in pediatric patients

Insulin pumps, digital technology and outcome analyses are useful tools


Victoria Johnson

Latest:

Serious adverse reaction halts gene therapy for diabetic macular edema

Despite setbacks in DME, Adverum Biotechnologies said it will continue to develop ADVM-022 for wet AMD.


Hashem Ghoraba, MD, MSc

Latest:

Ultra-widefield imaging: A critical step in uveitis diagnosis and management

A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.


Arshad M. Khanani, MD, MA, FASRS

Latest:

OPT-302 VEGF-C/D “trap” molecule for AMD promising in Phase 2b, moves to Phase 3

OPT-302 in combination with standard-of-care anti-VEGF-A agents shown to improve visual acuity, anatomic endpoints.



David A. Eichenbaum, MD

Latest:

Take-Home Points for the Treatment of AMD and DME

David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.



Konstantinos Balaskas, MB BS, MD, FEBO, MRCOPHTH

Latest:

How ophthalmology is pioneering the field of artificial intelligence

Retinal imaging tests are providing material to train and test decision support systems.


Marc Mathias, MD

Latest:

Pediatric ophthalmologists target inherited retinal diseases

New opportunities continue to develop in an evolving landscape.


Peter K. Kaiser, MD

Latest:

VEGF and beyond: therapeutic targeting in retinal vascular disorders

Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.


Mariya Moosajee, MBBS, BSc, PhD, FRCOphth

Latest:

Optimizing Care For Patients With Retinal Disorders

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.


Lee MacMorris

Latest:

OCT: First 2D image by Adolf Fercher paved the way for today’s imaging technique

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Adam M. Katz, MD

Latest:

Dexamethasone rebuttal: Who should perform intravitreal injections?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.


Sibylle Scholtz, PhD

Latest:

OCT: First 2D image by Adolf Fercher paved the way for today’s imaging technique

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Jose Agustin Martinez, MD, FASRS

Latest:

Significance of periphery in diabetic retinopathy diagnosis and management

Being able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.


Caroline Richards

Latest:

2023: What awaits ophthalmology in the year ahead

As we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.


Matthew Roe, MD, MHS

Latest:

Big data: Driving opportunity for real-world evidence

Evidence-based medicine can lead to personalized care, better results for patients


Jayanth Sridhar, MD

Latest:

Practice perspective: Academic retina

A window into the world of academic retina practice today.


Achim Langenbucher, PhD

Latest:

OCT: First 2D image by Adolf Fercher paved the way for today’s imaging technique

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Ramin Tadayoni, MD, PhD

Latest:

Discussing worldwide pathological myopia

Dr. Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.


Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Latest:

Ultra-widefield imaging: A critical step in uveitis diagnosis and management

A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.


Brian K. Do, MD

Latest:

Expanding our vision of steroid-eluting implants

How long-term intravitreal steroid technology fits into a modern clinic.


Marco Mura, MD

Latest:

Adapting medical retina service in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key


Szilárd Kiss, MD

Latest:

Perspectives on intravenous bevacizumab repackaged for intravitreal use

Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.


Michael W. Stewart, MD

Latest:

Dexamethasone rebuttal: Who should perform intravitreal injections?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.


Anat Loewenstein, MD, MHA

Latest:

Monitoring patients for neovascular AMD in the office and at home

Technology that allows consistent monitoring could be useful tools in 2022—and may be the key to tracking nAMD progression in fellow eyes among patients who have had intervals extended due to new technology.


Eduardo Uchiyama, MD

Latest:

Impressions and take away points from Patient Case #2

A retina specialist discusses impressions and key take away points from patient case.

© 2023 MJH Life Sciences

All rights reserved.